Eton Pharmaceuticals Inc. (ETON) Tops Q3 EPS by 6c

Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q3 EPS of ($0.12), $0.06 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $3.22 million versus the consensus estimate of $3 million.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.

You May Also Be Interested In

• Eton Pharmaceuticals (ETON) PT Raised to $65 at H.C. Wainwright
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance